Activin A is a differentiation factor for β-cells and is effective to promote β-cell neogenesis.
Activin A is also an autocrine activator of pancreatic stellate cells, which play a critical role in fibrogenesis of the pancreas.
Conophylline (CnP) is a natural compound, which reproduces the effect of
activin on β-cell differentiation and promotes β-cell neogenesis when administered in vivo. However, its effect on stellate cells is not known. We therefore investigated the effect of CnP on stellate cells both in vitro and in vivo. Unlike
activin A, CnP inhibited activation of cultured stellate cells and reduced the production of
collagen. We then analyzed the involvement of stellate cells in islet
fibrosis in Goto-Kakizaki (GK) rats, a model of
type 2 diabetes mellitus. In pancreatic sections obtained from 6-wk-old GK rats, CD68-positive macrophages and
glial fibrillary acidic protein- and α-smooth muscle actin-positive stellate cells infiltrated into islets. Later, the number of macrophages was increased, and the α-smooth muscle actin staining of stellate cells became stronger, indicating the involvement of stellate cells in islet
fibrosis in GK rats. When CnP was administered orally for 4 wk, starting from 6 wk of age, invasion of stellate cells and macrophages was markedly reduced and islet
fibrosis was significantly improved. The
insulin content was twice as high in CnP-treated rats. These results indicate that CnP exerts antifibrotic actions both in vitro and in vivo and improves islet
fibrosis in Goto-Kakizaki rats.